|
Report Date : |
06.10.2012 |
IDENTIFICATION DETAILS
|
Name : |
GETZ PHARMA
INTERNATIONAL FZ LLC |
|
|
|
|
Registered Office : |
Executive Office
No. 110, Building No. 3, 1st Floor, Dubiotech Business Centre, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
2006 |
|
|
|
|
Legal Form : |
Free Zone Company – FZ LLC |
|
|
|
|
Line of Business : |
Distributors of
pharmaceuticals and medicines. |
|
|
|
|
No. of Employees : |
6 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
|
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
UNITED ARAB
EMIRATES - ECONOMIC OVERVIEW
The UAE has an open economy with a high per capita
income and a sizable annual trade surplus. Successful efforts at economic
diversification have reduced the portion of GDP based on oil and gas output to
25%. Since the discovery of oil in the UAE more than 30 years ago, the UAE has
undergone a profound transformation from an impoverished region of small desert
principalities to a modern state with a high standard of living. The government
has increased spending on job creation and infrastructure expansion and is
opening up utilities to greater private sector involvement. In April 2004, the
UAE signed a Trade and Investment Framework Agreement with
|
Source
: CIA |
Company Name : GETZ PHARMA
INTERNATIONAL FZ LLC
Country of Origin :
Legal Form :
Free Zone Company – FZ LLC
Registration Date : 2006
Trade Licence
Number : 80022
Issued Capital :
UAE Dh 500,000
Paid up Capital : UAE Dh
500,000
Total Workforce : 6
Activities :
Distributors of pharmaceuticals and medicines.
Financial Condition : Undetermined
Payments :
Nothing detrimental uncovered
GETZ PHARMA INTERNATIONAL
FZ LLC
Building : Executive Office No. 110, Building No. 3, 1st
Floor
Area : Dubiotech Business Centre,
PO Box : 345018
Town :
Country : United Arab Emirates
Telephone : (971-4) 4494031
Facsimile : (971-4) 4494032
Email : info@getzpharma.com / faisal.anwar@getzpharma.com
Subject operates from
a small suite of offices that are rented and located in the Central Business
Area of Dubai.
Name Position
·
Khalid
Mahmoud Managing
Director
·
Reymond
Smikan Director
·
Imtiaz
Abdulrazzaq Business
Development Manager
·
Faisal
Anwar Financial
Controller
Date of Establishment : 2006
Legal Form :
Free Zone Company – FZ LLC
Trade Licence No. : 80022
Issued Capital : UAE Dh 500,000
Paid up Capital : UAE Dh 500,000
·
Khalid
Mahmoud
·
Reymond
Smikan
Activities: Engaged in the import and distribution of
pharmaceuticals and medicines.
Import
Countries: Europe and the
Subject has a
workforce of 6 employees.
Companies
registered in
·
HSBC
Bank
Deira Souk Branch
PO Box: 66
Tel: (971-4) 2535000
·
Habib
Bank Ltd
Murshid Bazaar
PO Box: 888
Tel: (971-4) 2221281
Fax: (971-4) 2284631
No complaints
regarding subject’s payments have been reported.
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.61 |
|
|
1 |
Rs.83.57 |
|
Euro |
1 |
Rs.67.17 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.